DrugCard Simple Search

DrugCard Simple Search is an AI-powered SaaS platform designed to streamline and automate pharmacovigilance processes, specifically the critical task of medical literature monitoring (MLM). It addresses the immense challenge of manually sifting through vast volumes of global scientific publications, regulatory documents, and local literature to identify adverse drug reaction (ADR) reports. The core value proposition lies in its ability to significantly reduce time-to-detection for potential drug safety signals, enhance compliance with regulatory requirements from agencies like the FDA and EMA, and minimize the risk of human error in this high-stakes field.

Key features: The platform offers automated, continuous scanning of a wide array of sources, including PubMed, Embase, and regional journals. It utilizes natural language processing (NLP) to extract and classify relevant ADR information, automatically generating case reports that can be fed into safety databases. Users can set up customized alerts for specific drugs, substances, or adverse events. The system also provides tools for deduplication, risk assessment scoring, and maintaining a complete audit trail for regulatory inspections, all within a centralized dashboard.

What sets DrugCard apart is its strong focus on local and non-English literature, which is often a blind spot in traditional monitoring but is crucial for global pharmacovigilance. The AI models are specifically trained on medical and pharmacological corpora, improving accuracy in entity recognition and context understanding over generic search tools. The platform is designed for seamless integration with existing pharmacovigilance systems and EudraVigilance, supporting automated data exchange via APIs to fit into established workflows without major disruption.

Ideal for pharmaceutical companies, contract research organizations (CROs), and biotechnology firms of all sizes that are mandated to perform systematic literature screening for drug safety. It is particularly valuable for safety officers, pharmacovigilance scientists, and regulatory affairs professionals who need to efficiently manage the MLM process, prepare for audits, and ensure timely reporting of safety information to health authorities worldwide.

The platform operates on a freemium model, providing basic search and alert functionality for free to allow teams to evaluate its core capabilities. For full-scale deployment with advanced analytics, priority support, and enterprise-level data processing, paid subscription plans are available, typically scaling with the volume of data processed and the number of users.